Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions
Tamer N. Jarada et al.
JOURNAL OF CHEMINFORMATICS (2020)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Network-based approach to prediction and population-based validation of in silico drug repurposing
Feixiong Cheng et al.
NATURE COMMUNICATIONS (2018)
Seeksv: an accurate tool for somatic structural variation and virus integration detection
Ying Liang et al.
BIOINFORMATICS (2017)
Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available
Miguel A. Hernan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
Real-World Evidence - What Is It and What Can It Tell Us?
Rachel E. Sherman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
DPDR-CPI, a server that predicts Drug Positioning and Drug Repositioning via Chemical-Protein Interactome
Heng Luo et al.
SCIENTIFIC REPORTS (2016)
Drug repositioning and repurposing: terminology and definitions in literature
Joris Langedijk et al.
DRUG DISCOVERY TODAY (2015)
Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality
Hua Xu et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2015)
Fenofibrate - A Potential Systemic Treatment for Diabetic Retinopathy?
Tien Yin Wong et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Predicting New Indications for Approved Drugs Using a Proteochemometric Method
Sivanesan Dakshanamurthy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Use of genome-wide association studies for drug repositioning
Philippe Sanseau et al.
NATURE BIOTECHNOLOGY (2012)
Exploiting drug-disease relationships for computational drug repositioning
Joel T. Dudley et al.
BRIEFINGS IN BIOINFORMATICS (2011)
The role of translational bioinformatics in drug discovery
Natalie S. Buchan et al.
DRUG DISCOVERY TODAY (2011)
PREDICT: a method for inferring novel drug indications with application to personalized medicine
Assaf Gottlieb et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome
Heng Luo et al.
NUCLEIC ACIDS RESEARCH (2011)
Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
Marina Sirota et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
A side effect resource to capture phenotypic effects of drugs
Michael Kuhn et al.
MOLECULAR SYSTEMS BIOLOGY (2010)
Discovery of drug mode of action and drug repositioning from transcriptional responses
Francesco Iorio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Effect of the angiotensin receptor blocker Valsartan on coronary microvascular flow reserve in moderately hypertensive patients with stable coronary artery disease
Takahiro Higuchi et al.
MICROCIRCULATION (2007)
Design issues of randomized phase II trials and a proposal for phase II screening trials
LV Rubinstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease - The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial
CJ Pepine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Efficient estimation of average treatment effects using the estimated propensity score
K Hirano et al.
ECONOMETRICA (2003)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
Share Paper
